**Funding information**

This work received funding from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) -- Supported Program for the Strategic Research Foundation at Private Universities, 2015--2019.

Introduction {#ams2424-sec-0002}
============

Patients who present with an overdose (OD) often ingest large amounts of psychotropic drugs. The diagnosis of an OD is usually based on a patient\'s complaint or the situation with scattered multiple empty charts as around a comatose patient. Drug urinary screening tests can be useful for detecting OD in unconscious patients. However, patients with OD often take psychotropic drugs regularly, so it can be difficult to diagnose OD correctly based solely on the results of screening tests.[1](#ams2424-bib-0001){ref-type="ref"} In addition, drug screening tests cannot identify patients with OD of major tranquilizers and/or selective serotonin reuptake inhibitors. Although a definitive diagnosis can be obtained by measuring the serum drug level, standard hospitals cannot easily measure the serum drug level at their facilities. Overdose is also difficult to diagnose in comatose patients who cannot talk or in patients who present without any remarkable evidence of OD.

Recently, there have been a number of reports concerning the utility of abdominal computed tomography (CT) for diagnosing OD.[1](#ams2424-bib-0001){ref-type="ref"}, [2](#ams2424-bib-0002){ref-type="ref"}, [3](#ams2424-bib-0003){ref-type="ref"}, [4](#ams2424-bib-0004){ref-type="ref"}, [5](#ams2424-bib-0005){ref-type="ref"}, [6](#ams2424-bib-0006){ref-type="ref"}, [7](#ams2424-bib-0007){ref-type="ref"}, [8](#ams2424-bib-0008){ref-type="ref"}, [9](#ams2424-bib-0009){ref-type="ref"}, [10](#ams2424-bib-0010){ref-type="ref"}, [11](#ams2424-bib-0011){ref-type="ref"}, [12](#ams2424-bib-0012){ref-type="ref"}, [13](#ams2424-bib-0013){ref-type="ref"}, [14](#ams2424-bib-0014){ref-type="ref"}, [15](#ams2424-bib-0015){ref-type="ref"}, [16](#ams2424-bib-0016){ref-type="ref"} We herein report the summary and results of an analysis of these reports to assess the significance of CT for patients with OD.

Methods {#ams2424-sec-0003}
=======

This study was approved by the Institutional Review Board of Juntendo Shizuoka Hospital (Izunokuni, Japan).

Searches of Ichushi (Japana Centra Revuo Medicine), which collects summaries of Japanese medical articles, and PubMed were undertaken on 20 February, 2019, to identify articles from 1983 to 2019 using the key words "poisoning" and "abdominal computed tomography". Additional articles were identified by a manual search of the references from the key articles. The inclusion criteria were reports describing cases of OD due to medical drugs and including data on patients and abdominal CT findings concerning drugs. Reports of body packers or stuffers and reports that did not describe an individual patients' data were excluded.

We collected patient data including sex, age, reason for poisoning, name of drug(s) involved, volume or serum level of drug(s), findings of abdominal CT concerning the drug(s), abdominal X‐ray findings (if relevant), duration from ingestion of drug(s) to CT, treatment, and final outcome.

Statistical analyses were carried out using the χ^2^‐test, if appropriate. Differences with *P*‐values of \<0.05 were considered to be statistically significant.

Results {#ams2424-sec-0004}
=======

We found 16 articles concerning OD including abdominal CT findings, excluding seven articles of body packers.[1](#ams2424-bib-0001){ref-type="ref"}, [2](#ams2424-bib-0002){ref-type="ref"}, [3](#ams2424-bib-0003){ref-type="ref"}, [4](#ams2424-bib-0004){ref-type="ref"}, [5](#ams2424-bib-0005){ref-type="ref"}, [6](#ams2424-bib-0006){ref-type="ref"}, [7](#ams2424-bib-0007){ref-type="ref"}, [8](#ams2424-bib-0008){ref-type="ref"}, [9](#ams2424-bib-0009){ref-type="ref"}, [10](#ams2424-bib-0010){ref-type="ref"}, [11](#ams2424-bib-0011){ref-type="ref"}, [12](#ams2424-bib-0012){ref-type="ref"}, [13](#ams2424-bib-0013){ref-type="ref"}, [14](#ams2424-bib-0014){ref-type="ref"}, [15](#ams2424-bib-0015){ref-type="ref"}, [16](#ams2424-bib-0016){ref-type="ref"} Of these, one report by Cha *et al*.[16](#ams2424-bib-0016){ref-type="ref"} did not describe the individual patients' data, so this report was excluded from the data analysis. Accordingly, 48 cases across 15 articles were defined as subjects in this report.

Table [1](#ams2424-tbl-0001){ref-type="table"} shows a summary of each subject\'s sex, age, reason for poisoning, findings of abdominal CT concerning the drug(s), abdominal X‐ray findings (if relevant), duration from ingestion of drug(s) to CT, treatment, and final outcome (Table [S1](#ams2424-sup-0001){ref-type="supplementary-material"}). There were 14 subjects who underwent both abdominal CT and X‐ray. Only one of the 14 subjects who underwent X‐ray were suggested to have ingested drugs; however, the CT findings in all 14 subjects suggested residual drugs in the stomach, which was a statistically significant difference (*P* \< 0.0001). All fatal cases underwent postmortem abdominal CT, and the subjects who were transported to the hospital not in cardiac arrest obtained a survival outcome.

###### 

Summary of background characteristics of subjects who underwent abdominal computed tomography (CT) for diagnosing overdose of ingested drugs (*n* = 48)

  ----------------------------------------------- -----------------------------
  Age (years)                                     16--91, average 46.8 ± 17.8
  Sex (male/female)                               20/28
  Reason for intoxication                         
  Suicide                                         24
  Accident                                        2 (dementia)
  Unknown                                         22 (discovered after death)
  CT findings, positive/negative                  45/3
  Abdominal X‐ray                                 
  Positive                                        1
  Negative                                        13
  Not performed                                   33
  Treatment                                       
  Gastric lavage, laxative, charcoal              12
  Gastric lavage                                  2
  Infusion only                                   5
  Gastric lavage, laxative, charcoal, endoscopy   1
  Gastric aspiration, charcoal                    1
  Charcoal, sodium bicarbonate                    1
  None (post‐mortem CT)                           26
  Outcome                                         
  Survival                                        22
  Death                                           26
  ----------------------------------------------- -----------------------------
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Table [2](#ams2424-tbl-0002){ref-type="table"} describes which drugs each subject took, volume or serum level of drug, and duration from ingestion of drugs to examination of CT. Thirty‐one of 48 subjects ingested multiple drugs, and 45 of 48 subjects ingested psychotropic drugs.

###### 

Detailed data of overdose for each subject who underwent abdominal computed tomography (CT)

  No.   Drug                                                                     Number or serum concentration                                                                          Duration from ingestion to CT examination   Primary reporter
  ----- ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------ ------------------------------------------- ------------------
  1     Bromovaleryl urea                                                        40                                                                                                     ?                                           Sagishima
  2     Antidiarrheal drug, Seirogan                                             Large number                                                                                           5                                           Kimura
  3     Sulpiride, maprotiline, biperiden, quetiapine                            ?                                                                                                      2                                           Kimura
  4     Zopiclone                                                                60                                                                                                     ?                                           Shikama
  5     Chlorpromazine, nitrazepam                                               ?                                                                                                      ?                                            
  6     Quetiapine, flunitrazepam                                                ?                                                                                                      ?                                           Terazumi
  7     Fenobarbital, chlorpromazine, promethazine, etizolam                     840                                                                                                    8                                           Yanagawa
  8     Zopiclone, mirtazapine                                                   420                                                                                                    10                                          Yanagawa
  9     Brotizolam                                                               12                                                                                                     8                                           Yanagawa
  10    Olanzapine, clonazepam, valproate, paroxetine                            3,482                                                                                                  6                                           Yanagawa
  11    Etizolam, loflazepate, paroxetine, haloperidol, flunitrazepam, lithium   40                                                                                                     12                                          Yanagawa
  12    Triazolam                                                                7                                                                                                      ?                                           Yanagawa
  13    Amobarbital, loflazepate                                                 1,122                                                                                                  8                                           Yanagawa
  14    Biperiden, loflazepate, risperidone, promethazine, levomepromazine       82                                                                                                     9                                           Yanagawa
  15    Nitrazepam, quazepam, flunitrazepam, promethazine                        2,911                                                                                                  12                                          Yanagawa
  16    Nitrazepam, triazolam                                                    130                                                                                                    4                                           Yanagawa
  17    Valproate                                                                ?                                                                                                      ?                                           Yanagawa
  18    Fluvoxamine, carbamazepine, zolpidem                                     3.0 μg/mL fluvoxamine, 8.7 μg/mL carbamazepine, 50 ng/mL zolpidem                                      1 day                                       Sano
  19    Chlorpromazine, phenobarbital                                            ?                                                                                                      1 and 3 days                                Miyamoto
  20    Calcium supplement                                                       30                                                                                                     ?                                           Kato
  21    Acetylsalicylic acid, triazolam, nitrazepam, imipramine, etizolam        746 μg/mL acetylsalicylic acid, 13.5 mg triazolam, 110 mg nitrazepam, 1 g imipramine, 68 mg etizolam   ?                                           Tominaga
  22    Imipramine                                                               ?                                                                                                      24                                          Nishikata
  23    Nifedipine, lisinopril, loxoprofen                                       180                                                                                                    3                                           Sakamoto
  24    Amobarbital, phenobarbital, pentobarbital                                13 μg/mL amobarbital, 122 μg/mL phenobarbital, 11 μg/mL pentobarbital                                  Several weeks                               Usui
  25    Triazolam                                                                100 ng/mL triazolam                                                                                    2 days                                      Usui
  26    Levomepromazine                                                          3 μg/mL levomepromazine                                                                                A few days                                  Usui
  27    Diphenhydramine, mianserin, zolpidem                                     10 μg/mL diphenhydramine, 443 ng/mL mianserin, 199 ng/mL zolpidem                                      A few days                                  Usui
  28    Amobarbital                                                              87 μg/mL amobarbital                                                                                   1 day                                       Usui
  29    Pentobarbital                                                            414 μg/mL pentobarbital                                                                                Several days                                Usui
  30    Zolpidem                                                                 917 μg/mL zolpidem                                                                                     1 day                                       Usui
  31    Pentobarbital, levomepromazine, nitrazepam                               33 μg/mL pentobarbital, 631 ng/mL levomepromazine, 225 ng/mL nitrazepam                                A few days                                  Usui
  32    Zolpidem                                                                 1,720 ng/mL zolpidem                                                                                   ?                                           Usui
  33    Milnacipran, zolpidem, paroxetine                                        19 μg/mL milnacipran, 1,180 ng/mL zolpidem, 904 ng/mL paroxetine                                       2 days                                      Usui
  34    Levomepromazine, olanzapine, phenobarbital, zopiclone                    2,100 ng/mL levomepromazine, 1,060 ng/mL olanzapine, 80 μg/mL phenobarbital, 659 ng/mL zopiclone       A few days                                  Usui
  35    Olanzapine                                                               1,020 ng/mL olanzapine                                                                                 A few days                                  Usui
  36    Salicyclic acid                                                          429 μg/mL salicyclic acid                                                                              A few days                                  Usui
  37    Olanzapine, zolpidem                                                     247 ng/mL olanzapine, 330 ng/mL zolpidem                                                               A few days                                  Usui
  38    Amobarbital, pentobarbital, triazolam                                    14 μg/mL amobarbital, 17 μg/mL pentobarbital, 7 ng/mL triazolam                                        A few days                                  Usui
  39    Levomepromazine, haloperidol                                             949 ng/mL levomepromazine, 59 ng/mL haloperidol                                                        A few days                                  Usui
  40    Flunitrazepam                                                            106 ng/mL flunitrazepam                                                                                1 day                                       Usui
  41    Amitriptyline, nortriptyline                                             6,060 ng/mL amitriptyline, 902 ng/mL nortriptyline                                                     A few days                                  Usui
  42    Olanzapin, phenobarbital, promethazine                                   406 ng/mL olanzapin, 154 μg/mL phenobarbital, 997 ng/mL promethazine                                   A few days                                  Usui
  43    Levomepromazine, mirtazapine, zolpidem                                   3,890 ng/mL levomepromazine, 6,020 ng/mL mirtazapine, 332 ng/mL zolpidem                               1 day                                       Usui
  44    Promethazine, sulpride                                                   245 ng/mL promethazine, 2,170 ng/mL sulpride                                                           A few days                                  Usui
  45    Levomepromazine, promethazine, zopiclone                                 1,880 ng/mL levomepromazine, 919 ng/mL promethazine, 445 ng/mL zopiclone                               A few days                                  Usui
  46    Olanzapine                                                               1,100 ng/mL olanzapine                                                                                 A few days                                  Usui
  47    ?                                                                        ?                                                                                                      ?                                           Garetier
  48    Mirtazapine, eszopiclone                                                 ?                                                                                                      ?                                           Nagasawa

?, unknown.
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Table [3](#ams2424-tbl-0003){ref-type="table"} shows a summary of the abdominal CT findings concerning drugs. Forty‐five of the 48 subjects (93.8%) had positive findings of residual drugs on CT. The finding of a high‐density fluid level in the stomach was the most frequent (60.4%), followed by ill‐defined high‐density material in the stomach (12.5%) and high‐density tablets in the stomach (10.4%).

###### 

Summary of computed tomography findings in patients with overdose of ingested drugs (*n* = 48)

  -------------------------------------------------- ----
  High‐density fluid level in stomach                29
  Ill‐defined high‐density material in the stomach   6
  High‐density tablets in stomach                    5
  High‐density ball in stomach                       1
  High‐density area in gastric fluid                 1
  Relatively high‐density gastric fluid              1
  High‐density in stomach                            1
  High‐density in duodenum                           1
  None                                               3
  -------------------------------------------------- ----
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Discussion {#ams2424-sec-0005}
==========

This mini review revealed that 93.8% patients with OD had positive findings of residual drugs on abdominal CT, suggesting that CT is more sensitive for detecting residual drugs in the stomach than X‐ray. Of note, a high‐density fluid level in the stomach was the most frequent finding on CT.

Cha *et al*. reported the results of a prospective cohort study of patients with OD who were admitted to the emergency department between March 2017 and February 2018. They evaluated the prevalence of drugs in the gastric lumen using abdominal plain CT. Among 140 subjects, residual drugs, defined as a round‐shaped lesion with a higher density than the gastric mucosa on CT, were detected in 36 patients (25.7%). In addition, 58 patients (41.4%) showed a positive radiodense image in the stomach, defined as an artifact with a higher density than the gastric mucosa on CT. One reason for the difference in the ratio of positive findings on CT between the study of Cha *et al*.[16](#ams2424-bib-0016){ref-type="ref"} and the present study could be the severity of the patients with OD. Their study included patients encountered between 1 and 12 h after ingesting drugs and who met the following criteria: (i) ingestion of more than three times the therapeutic dose of a drug with signs and symptoms, (ii) known or reported life‐threatening drugs, (iii) overdose of multiple classification drugs or sustained‐release drugs, (iv) unknown type of ingested drug, (v) known type of drug but no information about amount ingested, with symptoms and/or signs of OD. In contrast, our subjects included those with a postmortem study, accounting for 26 of the 48 cases (54.2%), compared with just two fatal cases (1.4%) in Cha *et al*.\'s study. Accordingly, the present study included more severely ill patients with OD, suggesting a greater quantity of ingested drugs than in Cha *et al*.\'s study. This difference might have resulted in the high frequency of positive findings on CT in the present study. However, the present study less frequently showed round‐shaped lesions in the stomach than the study of Cha *et al*.,[16](#ams2424-bib-0016){ref-type="ref"} a finding that indicated high‐density tablets. This might be due to the timing of the CT examination, as the present study included subjects in whom CT was carried out several days or weeks after drug ingestion. This delayed timing of CT could have resulted in the drugs being dissolved in the gastric juice.

Undertaking an abdominal CT examination in unconscious patients is important for obtaining clues to aid in the diagnosis of an OD. Unconscious patients who cannot supply information about a potential OD could die without treatment with an appropriate antagonist and/or decontamination.[17](#ams2424-bib-0017){ref-type="ref"} Abdominal CT can also provide clues to aid in identifying OD patients who need decontamination in order to obtain an early recovery. Cha *et al*.[16](#ams2424-bib-0016){ref-type="ref"} undertook decontamination when abdominal CT showed positive findings. As a result, the total duration of the hospital stay was significantly longer in cases of negative CT findings than in those with positive findings.

Several limitations associated with the present study warrant mention. Computed tomography requires patients presenting with OD, whose prognosis is usually favorable, to undergo radiation exposure. In addition, CT is able to detect the contents of the stomach, although the details thereof cannot be determined using CT alone. Accordingly, further studies are required to determine the level of drugs in the gastric juice and/or blood for an accurate diagnosis of OD. Additionally, a large amount of drugs can move into the intestine and thus be absorbed, and therefore such absorbed drugs might no longer be detected by CT examinations. Therefore, it is necessary to determine how long after ingestion CT is effective for indicating high‐density areas of residual drugs in the stomach.

Conclusion {#ams2424-sec-0006}
==========

This mini‐review suggested that a high‐density fluid level or high‐density tablets in the stomach on abdominal CT can be indicative of the presence of an OD of ingested drugs. Accordingly, CT findings could provide a clue to aid in the diagnosis of OD in comatose patients who cannot talk or who present without any other evidence of OD. In addition, a recent study revealed the merits of decontamination for patients with positive findings on the CT even if more than 60 min had elapsed since the ingestion of drugs.
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###### 

**Table S1** Each subject\'s sex, age, reason for poisoning, findings on abdominal computed tomography (CT) concerning the drug(s), abdominal X‐ray findings (if relevant), duration from ingestion of drug(s) to CT, treatment, and final outcome.

###### 

Click here for additional data file.
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